Member States’ competent authorities should share between themselves and with the Commission, through the European database on drug precursors (‘the European database’), established under Regulation (EC) No 273/2004 of the European Parliament and of the Council [Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors (OJ L 47, 18.2.2004, p. 1).], information on seizures and stopped shipments in order to improve the overall level of information on trade in drug precursors, including medicinal products. The European database should be used to simplify the reporting by Member States with regard to seizures and stopped shipments. It should also serve as a European register of operators holding a licence or registration which will facilitate verification of the legitimacy of their transactions involving scheduled substances, and should enable operators to provide the competent authorities with information about their export, import or intermediary activities involving scheduled substances. That European register should be regularly updated and the information it contains should be used by the Commission and Member States’ competent authorities only for the purpose of preventing the diversion of drug precursors onto the illegal market.
Recital 11, Regulation (EU) No 1259/2013 of the European Parliament and of the Council of 20 Novembe…
In forcesince 20 Nov 2013